Feature Channels:

Pharmaceuticals

Add to Favorites Subscribe Share
fbshare-Pharmaceuticals

Showing results

110 of 3503
WFBH_color.jpg

Article ID: 720872

Scientists at Wake Forest School of Medicine Identify Genetic Variation Linked to Severity of ALS

Wake Forest Baptist Health

A discovery made several years ago in a lab researching asthma at Wake Forest School of Medicine may now have implications for the treatment of amyotrophic lateral sclerosis (ALS), a disease with no known cure and only two FDA-approved drugs to treat its progression and severity.

Released:
16-Oct-2019 12:30 PM EDT
Open in New Tab
Comment

Research Results

Channels:

All Journal News, Genetics, Neuro, Pharmaceuticals,

Languages:

English

Newswise: UIC College of Pharmacy honored for diversity, inclusion

Article ID: 720852

UIC College of Pharmacy honored for diversity, inclusion

University of Illinois at Chicago

The University of Illinois at Chicago College of Pharmacy has received the 2019 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine.

Released:
16-Oct-2019 10:05 AM EDT
Open in New Tab
Comment

Education

Announcement

Channels:

Education, Pharmaceuticals,

Languages:

English

UCD-logo.png

Article ID: 720738

Drug-light combo could offer control over CAR T-cell therapy

University of California San Diego

UC San Diego bioengineers are a step closer to making CAR T-cell therapy safer, more precise and easy to control. They developed a system that allows them to select where and when CAR T cells get turned on so that they destroy cancer cells without harming normal cells. The system requires two “keys”—the drug Tamoxifen and blue light—to activate CAR T cells to bind to their targets. Just one key keeps the cells inactive.

Released:
14-Oct-2019 7:05 PM EDT
Open in New Tab
Comment
UCSFLogo_1.png

Article ID: 720708

Dementia spreads via connected brain networks

University of California, San Francisco (UCSF)

In a new study, UC San Francisco scientists used maps of brain connections to predict how brain atrophy would spread in individual patients with frontotemporal dementia (FTD)

Released:
14-Oct-2019 1:05 PM EDT
Open in New Tab
Comment
PennMed_logo.png

Article ID: 720676

“Back in Time”: Penn Researchers Unravel the Early Makings of an Exhausted T Cell

Perelman School of Medicine at the University of Pennsylvania

Penn Medicine researchers explore a T cell's path to exhaustion and what triggers it.

Released:
14-Oct-2019 9:30 AM EDT
Open in New Tab
Comment
Embargo will expire:
21-Oct-2019 8:00 AM EDT
Released to reporters:
14-Oct-2019 8:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Oct-2019 8:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
21-Oct-2019 8:00 AM EDT
Released to reporters:
14-Oct-2019 8:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Oct-2019 8:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
19-Oct-2019 10:30 AM EDT
Released to reporters:
14-Oct-2019 8:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 19-Oct-2019 10:30 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
23-Oct-2019 2:00 PM EDT
Released to reporters:
14-Oct-2019 8:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 23-Oct-2019 2:00 PM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
21-Oct-2019 8:00 AM EDT
Released to reporters:
14-Oct-2019 8:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 21-Oct-2019 8:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.


Showing results

110 of 3503

Chat now!